DOSHI DIPAL (President and CEO) received a stock award from ENTRADA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001613084-26-000001
DirectorOfficer· President and CEO
Since Oct 2021
+318.35K
Net shares
Net buyer
$340.6K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
347.40K acquired · 29.05K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+139.40K
Price / share
—
Trade value
—
% of position
33.5%
3/1/2026
415.66K→555.06K
Common Stock
Direct
Shares
−9.87K
Price / share
$11.66
Trade value
$115.05K
% of position
1.8%
3/2/2026
555.06K→545.20K
Common Stock
Direct
Shares
−19.18K
Price / share
$11.76
Trade value
$225.50K
% of position
3.5%
3/3/2026
545.20K→526.01K
Total
Net shares
+110.35K
Net value
-$340.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +139.40K | — | — | 33.5% | 415.66K | 555.06K |
| Common Stock Direct | 3/2/2026 | F · Tax Withholding | −9.87K | $11.66 | $115.05K | 1.8% | 555.06K | 545.20K |
| Common Stock Direct | 3/3/2026 | F · Tax Withholding | −19.18K | $11.76 | $225.50K | 3.5% | 545.20K | 526.01K |
| Total | +110.35K | -$340.55K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
208K shares
Shares
+208K
Strike price
11.93
Held after
208K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock208K shares | 3/1/2026 | A · Award | +208K | 11.93 | — | 208K |